General form for registration of securities under the Securities Act of 1933

Condensed Consolidated Statements of Cash Flows

v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:        
Net loss $ (5,136,000) $ (5,495,000) $ (6,674,000) $ (8,333,000)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:        
Depreciation and amortization 747,000 750,000 1,002,000 1,045,000
Stock-based compensation 734,000 831,000 979,000 1,571,000
Amortization of debt issuance costs 57,000 123,000 164,000 230,000
Allowance for credit losses 12,000 1,000    
Non-cash lease expense 547,000 493,000 667,000 606,000
Inventory write downs 86,000 592,000 534,000 490,000
Changes in operating assets and liabilities:        
Accounts receivable 7,498,000 (197,000) (1,723,000) (973,000)
Inventories 489,000 (48,000) (788,000) (1,309,000)
Other assets (613,000) 259,000 (1,085,000) (163,000)
Accounts payable (8,027,000) 3,471,000 5,022,000 1,523,000
Accrued expenses (1,421,000) 1,759,000 3,132,000 745,000
Accrued interest (20,000) 68,000 120,000 124,000
Office leases payable (617,000) (543,000) (734,000) (644,000)
Deferred revenue (25,000) 124,000 (26,000) 354,000
Customer deposits 24,000 20,000 20,000 (64,000)
Net cash (used in) provided by operating activities (5,665,000) 2,208,000 610,000 (4,798,000)
Cash flows from investing activities:        
Purchases of equipment (405,000) (498,000) (653,000) (853,000)
Net cash used in investing activities (405,000) (498,000) (653,000) (853,000)
Cash flows from financing activities:        
Proceeds from issuance of preferred and common stock warrants under Private Placement 3,827,000    
Offering costs for issuance of preferred and common stock warrants (652,000)    
Proceeds from issuance of common stock under Public Offering 11,040,000    
Offering costs for issuance of common stock (1,280,000)    
Proceeds from employee stock purchase plan exercises     97,000 141,000
Proceeds from subordinated debt borrowing 1,000,000 1,000,000
Proceeds from stock option exercises and employee stock purchase plan purchases 311,000 98,000    
Proceeds from revolving line of credit 46,831,000 46,914,000 64,463,000 67,209,000
Payment of revolving line of credit (54,736,000) (49,744,000) (64,670,000) (63,287,000)
Cost to amend line of credit agreement (113,000)    
Payment of finance leases (120,000) (116,000) (156,000) (148,000)
Net cash provided by (used in) financing activities 5,108,000 (1,848,000) 734,000 3,915,000
Net change in cash (962,000) (138,000) 691,000 (1,736,000)
Cash, beginning of period 1,334,000 643,000 643,000 2,379,000
Cash, end of period 372,000 505,000 1,334,000 643,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:        
Right-of-use asset recognition 139,000    
Preferred and common stock warrants issued under Private Placement in exchange for settlement of subordinated debt, including interest accrued 1,173,000    
Common stock issued for vested RSUs 65,000 161,000 538,000
Warrants issued in connection with borrowing agreements, recorded as debt issuance cost     92,000
Supplemental Cash Flow Information:        
Interest paid $ 766,000 $ 947,000 $ 1,235,000 $ 1,409,000